CenterStar Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

CenterStar Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$983K	Buy	2,000 +1,100	+122%	+$597K	0.12%	192
2025 Q4	$522K	Buy	+900	New	+$509K	0.15%	148
2023 Q4	–	Sell	-600	Closed	-$304K	–	428
2023 Q3	$304K	Sell	600 -1,400	-70%	-$746K	0.06%	254
2023 Q2	$1.04M	Buy	2,000 +700	+54%	+$378K	0.11%	117
2023 Q1	$749K	Buy	+1,300	New	+$733K	0.28%	76
2022 Q3	–	Hold	0	–	-$268K	–	484
2022 Q2	–	Hold	0	–	–	–	261
2022 Q1	–	Hold	0	–	–	–	211
2021 Q4	–	Hold	0	–	-$823K	–	830
2021 Q3	–	Hold	0	–	–	–	280
2021 Q2	–	Hold	0	–	–	–	77
2021 Q1	–	Hold	0	–	–	–	73
2020 Q2	–	Hold	0	–	-$2K	–	896
2020 Q1	–	Hold	0	–	–	–	707
2019 Q4	–	Hold	0	–	–	–	468
2018 Q4	–	Hold	0	–	-$7K	–	759
2018 Q3	–	Hold	0	–	–	–	592
2018 Q2	–	Hold	0	–	-$41K	–	1075
2018 Q1	–	Hold	0	–	–	–	579
2017 Q4	–	Hold	0	–	–	–	311

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CenterStar Asset Management's TMO Position: Q3 2023 in Review

CenterStar Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 3,448 shares — an estimated $1.84M sold.

CenterStar Asset Management first reported a position in TMO in Q1 2023 and held it in 2 quarters. The position peaked at $1.8M in Q2 2023. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

CenterStar Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
CenterStar Asset Management sold 3,448 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.84M.
CenterStar Asset Management first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 2 quarters.
CenterStar Asset Management's Thermo Fisher Scientific position peaked at $1.8M in Q2 2023.
2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on CenterStar Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.